Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + minocycline vs vonoprazan + amoxicillin for first-line Helicobacter pylori eradication
ChiCTR2500102272Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Helicobacter pylori infection comparing Vonoprazan + minocycline dual therapy with Vonoprazan + amoxicillin dual therapy (2 arms). Primary endpoints: Helicobacter pylori eradication rate and Adverse events. Planned start May 2025; status: not yet recruiting.
02
Drugs
vonoprazanminocyclineamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2500102272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102272.